Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Private pay programs eliminate insurance delays and cost $300-500 monthly, allowing immediate treatment access with flexible scheduling
The better choice is the one that works best for your unique situation
Zunveyls approval is backed by chemistry, manufacturing and controls information and data demonstrating its bioequivalence and tolerability compared to galantamine immediate-release tablets and galantamine extended-release capsules
Medication Charts: Access medication charts from reputable health websites or consult your healthcare provider
Based on comparable drugs, expect $1,200 to $1,800 per month at launch without insurance or manufacturer discounts
P =0.61), squamous cell carcinoma (RR, 1.45
US$ 23.09
US$ 25.38
US$ 22.33
US$ 23.75
US$ 25.54
US$ 21.27
